Published in

American Society for Microbiology, Microbiology Spectrum, 4(10), 2022

DOI: 10.1128/spectrum.02006-22

Links

Tools

Export citation

Search in Google Scholar

Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants

Journal article published in 2022 by Karoline Leuzinger ORCID, Tim Roloff, Adrian Egli, Hans H. Hirsch ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Antigen tests are widely used for rapid identification of SCoV2-positive cases and their increased risk of transmission. At present, there are several FDA- and CE-cleared tests available in North America and Europe.